https://www.selleckchem.com/pr....oducts/vorolanib.htm
51, 95% CI 1.23-5.10 for PFS and HR = 2.60, 95% CI 1.19-5.67 for OS) were found to be significant predictors. Among the three indices, ALI 20.4 identified the patients with the worst 5-year outcomes. Moreover, patients with a combination of low PNI and low ALI resulted to be a better predictor of progression (HR = 5.26, 95% CI 2.01-13.73) and death (HR = 5.68, 95% CI 1.92-16.79) than low ALI and low PNI considered alone. Our results support the use of pre-treatment ALI, an easily measurable inflammatory/nutritional index, in dail
Like
Comment
Share
